Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The WISEWOMAN program: reflection and forecast.

Julie C Will1, Ryan K Loo

  • 1Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, 4770 Buford Hwy, NE, Mailstop K-77, Atlanta, GA 30341, USA. jwill@cdc.gov

Preventing Chronic Disease
|March 18, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association Between Self-Reported Hypertension and Antihypertensive Medication Use and Cardiovascular Disease-Related Events and Expenditures Among Patients Diagnosed With Hypertension.

Public health reports (Washington, D.C. : 1974)·2019
Same author

Modeled Health and Economic Impact of Team-Based Care for Hypertension.

American journal of preventive medicine·2016
Same author

Medication Adherence and Incident Preventable Hospitalizations for Hypertension.

American journal of preventive medicine·2015
Same author

Trends in predicted risk for atherosclerotic cardiovascular disease using the pooled cohort risk equations among US adults from 1999 to 2012.

JAMA internal medicine·2014
Same author

Evaluation of the South Dakota fitCare child care provider training program targeting nutrition and physical activity.

South Dakota medicine : the journal of the South Dakota State Medical Association·2014
Same author

National trends in the prevalence and medical history of angina: 1988 to 2012.

Circulation. Cardiovascular quality and outcomes·2014
Same journal

Parental Perceived Stress and Its Association With Childhood Obesity in Spain: The PASOS Study.

Preventing chronic disease·2026
Same journal

Predictors of Voucher Redemption in Produce Prescription Programs in a Primarily Low-Income Population With Type 2 Diabetes.

Preventing chronic disease·2026
Same journal

Cross-Sectional and Longitudinal Associations Between Weight Perception and Cardiometabolic Health Among Adolescents Followed Into Emerging Adulthood.

Preventing chronic disease·2026
Same journal

Prevalence and Correlates of Caregiver-Reported Disordered Eating Behaviors and Concerns Among US Children and Adolescents Aged 6 to 17 Years, 2022.

Preventing chronic disease·2026
Same journal

Changes in Sugar-Sweetened Beverage Intake From Before to After Nutrition Labeling Policy Implementation: A Comparison of Mexico and the United States.

Preventing chronic disease·2026
Same journal

Faith, Hope, and Therapy: A Qualitative Study to Explore Faith-Based Leaders' Perceptions of Mental Illness in the Rural South.

Preventing chronic disease·2026
See all related articles

The WISEWOMAN program enhances chronic disease prevention for low-income women. Phase III introduces new initiatives to address identified challenges and improve heart disease and stroke risk reduction.

Area of Science:

  • Public Health
  • Preventive Medicine
  • Health Services Research

Background:

  • The WISEWOMAN program targets women aged 40-64 who are low-income, underinsured, or uninsured.
  • The program focuses on screening and interventions to reduce risks of heart disease, stroke, and other chronic diseases.
  • Program design and findings from Phase I and Phase II have been previously published.

Purpose of the Study:

  • To summarize remaining challenges identified through systematic research and evaluation.
  • To outline initiatives for Phase III of the WISEWOMAN program.
  • To provide a framework and vision for program sustainability and community support.

Main Methods:

  • Systematic research and evaluation to identify program challenges.
  • Development of new initiatives for Phase III.

Related Experiment Videos

  • Framework and vision development for stakeholders.

    • Main Results:

    • Identified challenges from Phases I and II.
    • Proposed Phase III initiatives including varied intervention intensities, community health resources, and evidence-based interventions via a Center of Excellence.
    • A framework and vision for organizational, community, and other partners.

    Conclusions:

    • Phase III of the WISEWOMAN program will address identified challenges with new strategies.
    • The program aims to improve chronic disease risk reduction for its target population.
    • A collaborative framework is proposed to ensure program success and community impact.